| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06450041 | NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb)… | Neuroblastoma | Recruiting |
| NCT07261241 | NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab | Neuroblastoma | Not Yet Recruiting |
| Phase 1 | |||
| NCT02298348 | Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory… | Neuroblastoma | Active, Not Recruiting |
| NCT02573896 | Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells | Neuroblastoma | Active, Not Recruiting |
| Not specified | |||
| NCT01587300 | Neuroblastoma Biology Study | Neuroblastoma | Recruiting |
| NCT02868268 | Neuroblastoma Precision Trial | Neuroblastoma | Active, Not Recruiting |